The conserved nuclear factor I (NFI) family of transcription factors is unique to animals and essential for mammalian development. The Caenorhabditis elegans genome encodes a single NFI family member, whereas vertebrate genomes encode 4 distinct NFI protein subtypes (A, B, C, and X). NFI-1-deficient worms exhibit abnormalities, including reduced lifespan, defects in movement and pharyngeal pumping, and delayed egg-laying. To explore the functional basis of these phenotypes, we sought to comprehensively identify NFI-1-bound loci in C. elegans. We first established NFI-1 DNA-binding specificity using an in vitro DNA-selection strategy. Analysis yielded a consensus motif of TTGGCA(N) 3TGCCAA, which occurs 586 times in the genome, a 100-fold higher frequency than expected. We next asked which sites were occupied by NFI-1 in vivo by performing chromatin immunoprecipitation of NFI-1 followed by microarray hybridization. Only 55 genomic locations were identified, an unexpectedly small target set. In vivo NFI-1 binding sites tend to be upstream of genes involved in core cellular processes, such as chromatin remodeling, mRNA splicing, and translation. Remarkably, 59 out of 70 (84%) of the C. briggsae orthologs of the identified targets contain conserved NFI binding sites in their promoters. These experiments provide a foundation for understanding how NFI-1 is recruited to unexpectedly few in vivo sites to perform its developmental functions, despite a vast over-representation of its binding motif.
T
he Nuclear Factor I (NFI) DNA-binding proteins comprise a family of animal-specific transcription factors, with 4 members in vertebrates (NFIA, NFIB, NFIC, and NFIX) (1) . NFI family members play major roles in specific aspects of mammalian organogenesis. Mice lacking either NFIA or NFIB exhibit forebrain defects and perinatal lethality (2, 3) . In NFIB-deficient mice, these are accompanied by a failure in lung maturation (4) . Mice lacking NFIC lack molar tooth roots and exhibit incisor defects (5) . The human NFI proteins have analogous developmental functions. For example, individuals with 1 mutant copy of NFIA exhibit central nervous system malformations and urinary tract defects because of haploinsufficiency (3) . The NFI family has a single member in simpler multicellular animals, including Caenorhabditis elegans and Drosophila. C. elegans NFI-1 (pronounced ''NF oneone'') has 4 known splice variants, each of which create very similar 86-88 kDa proteins. Amino acid homology to mammalian NFI proteins is limited to the DNA-binding domain. Loss of nfi-1 in C. elegans results in a decreased rate of pharyngeal pumping, impaired egg-laying, altered motility, and a shortened lifespan (6) . NFI-1 seems to function autonomously in the pharyngeal muscle with respect to pumping and lifespan (7) .
Two primary questions surrounding NFI function relate to the identity of its binding targets in living cells, and how the selection of these in vivo targets is influenced by DNA sequence and chromatin. Previous studies of NFI-binding specificity used direct affinity isolation of transcription factor binding sites from the human genome (8) , selection on oligonucleotide libraries (9) , or bioinformatic comparison of motifs held in common by the promoters of putative NFI-regulated genes (10) . NFI proteins have been linked to chromatin because both NFI and glucocorticoid receptor (GR) binding influence mouse mammary tumor virus (MMTV) promoter chromatin structure (11) , and NFI proteins have functional and physical interactions with histones H1 and H3 (12, 13) .
Here, we show that the binding specificity of NFI-1 is similar to the consensus sequence recognized by vertebrate NFI orthologs. Remarkably, NFI-1 motifs are present at Ϸ100 times their expected frequency in the worm genome. Through ChIP experiments, we show that despite this high abundance, only a small fraction of the sites appear to be occupied in vivo. These targets appear to be evolutionarily conserved because orthologs of C. elegans NFI-1 targets in C. briggsae contain conserved NFI motifs in their promoters. In addition, 2 of the mouse and human orthologs of the C. elegans NFI-1 targets contain conserved motifs in their promoters and may have relevance to NFI family members knockout phenotypes.
Results
The DNA Binding Specificity of C. elegans NFI-1 Is Nearly Identical to That of Vertebrate NFIs. We reasoned that unbiased identification of NFI-1 binding sites with naked genomic DNA in the absence of influence from chromatin and other cofactors would provide a foundation for investigation of the in vivo targets of NFI-1 [supporting information (SI) Fig. S1 ]. C. elegans genomic DNA was digested with Sau3A and fragments were selected for binding to immobilized GST-NFI-1 fusion protein. After elution, ligation of linkers, and PCR amplification, the selected DNA was subjected to 2 additional rounds of selection and amplification, following by TA-cloning and sequencing. The efficiency of each round of genomic selection was assessed by competition with a perfectmatch oligonucleotide in a gel-shift assay (see Materials and Methods). As expected, DNA derived from each successive round of selection was increasingly able to compete with the perfectmatch oligonucleotide (see Fig. S1 ). After 3 rounds of selection, 53 clones were obtained, representing 14 unique sequences. Alignment of the 14 sequences revealed a consensus sequence of TTGGCA(N) 3 TGCCAA, which is nearly identical to the binding sequence reported previously for vertebrate NFIs [TTGGC-(N) 5 GCCAA] (Fig. 1A ) (see Materials and Methods) (10) . The C. elegans consensus appears to have additional specificity at nucleotides 8 and 12, which flank the central spacer region (Fig. 1B ).
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The DNA Sequence Bound by NFI-1 Occurs 100 Times More Often than
Expected in the C. elegans Genome. We searched for the TTGGC(N) 5 GCCAA motif in the C. elegans genome to create a catalog of potential NFI-1 binding sites. We found that NFI-1 consensus motifs containing either the N 5 spacer or the more specific AN 3 T spacer were distributed relatively uniformly across each chromosome, with the exception of a noticeable clustering on the arms of chromosomes V and X (Fig. 1C and Fig. S2 , and see Discussion). We were surprised to find 877 TTGGC(N) 5 GCCAA motifs in the C. elegans genome, Ϸ10-fold more than would be predicted mathematically from genomic sequence composition (Fig. 1D ). This over-representation was very specific to functional characteristics of the NFI-1 binding motif and was not observed in vertebrate genomes (Fig. S3 ). For example, over-representation was observed when the TTGGC and GCCAA portions of the motif were separated by a 5-nucleotide spacer, but not with 1-, 2-, 3-, 4-, 6-, 7-, 8-, 9-, 10-, or 15-nucleotide spacers (see Fig. 1D ). Furthermore, the more specific TTGGCA(N) 3 TGCCAA motif was present at over 100 times its expected frequency. Of the 877 TTGGC(N) 5 GCCAA motifs throughout the genome, 67% (586) contain the A(N) 3 T spacer, far above the expected frequency. No such overrepresentation was seen when TA, CG, or GC were used in the first and last positions of the 5-bp spacer (Fig. 1E) , or when each half of the consensus is reversed (TGCCAA(N) 3 TTGGCA).
Despite the Over-Representation of NFI-1-Binding Sequences, NFI-1 Binds to Few Targets in Vivo. To characterize direct in vivo targets of C. elegans NFI-1, we performed ChIP-chip experiments using extracts prepared from mixed stage wild-type worms (see Materials and Methods). Despite 877 perfect-match consensus sequences in the genome, we detected only 55 sites of NFI-1 binding (see Materials and Methods). To verify the microarray results, several loci were selected for analysis by qPCR: 9 ChIP-chip-positive loci with an NFI-1 motif, 4 ChIP-chippositive loci without an NFI-1 motif, 6 ChIP-chip-negative loci with an NFI motif, and 4 randomly selected ChIP-chip-negative loci (Fig. S4) . The qPCR results confirm the in vivo specificity of NFI-1 for the consensus motif and validate the microarray results. For example, at the eft-2 promoter, which contains a single NFI-1 motif, the highest enrichment as measured by qPCR occurs directly at the NFI-1 motif (Fig. 2A) .
The 55 NFI-1 target loci correspond to 85 downstream genes involved in basal cellular functions, including transcription, translation, biosynthesis, and GTPase signaling (Table 1) . NFI-1 targets tend to be highly expressed and expressed throughout the A list of the 55 NFI-1 in vivo targets. ЉPeak center coordinateЉ refers to the center of the maximum probe coordinate; after peak finding, all peaks were assigned to a 1,500-bp window centered on this coordinate for motif analysis. ЉPeak P-valueЉ refers to the CHIPOTle (34) P-value. Motif distance and annotations are to the nearest TSS; in the case of bidirectional promoters only the closest gene is shown. Peaks were annotated using the maximum probe center to the nearest gene using CEAS (35) . Gene descriptions are based on wormbase release ws192.
C. elegans lifecycle (Fig. S5) . All NFI-1-bound sites were located within 3.5 kb of a transcription start site (TSS) (Fig. S2B) . NFI-1-bound loci were under-represented on chromosomes V and X, in contrast to the over-abundance of binding motifs on those chromosomes (see Fig. S2 A) .
Genes required for viability (Emb, Lva, Lvl phenotypes), fertility (Ste, Stp), growth (Gro), and vulval development (Pvl, Mvl) are over-represented in the NFI-1 target set (see Fig. 2B ). In addition, we observe a significant over-representation of genes required for wild-type locomotion (Unc) and egg-laying (Egl). Misregulation of these target genes may contribute to the egg-laying and locomotion defects of nfi-1 loss-of-function mutants. There is also a significant enrichment of genes that when mutated yield a ''fat content reduced'' phenotype (14) , which may contribute to the lifespan phenotype of nfi-1 mutants. The varied phenotypes associated with loss of function of NFI-1 targets are consistent with the varied, relatively weak phenotypes observed with nfi-1 loss. Rather than functioning as a master regulator of any single process, NFI-1 may serve as a cofactor modulating transcription in several pathways.
The in Vivo DNA-Binding Specificity of NFI-1 Is Indistinguishable from Its Specificity in Vitro. We sought to determine whether the fact that NFI-1 bound few sites in vivo could be accounted for by a different DNA-binding specificity for NFI-1 in vivo. We ranked in vivo target loci by their amplitude, and extracted 1,500 bp of DNA sequence centered on the maximum probe for input to the motif discovery program MDscan (see Materials and Methods) (15) . All 20 of the reported motifs were highly similar to the in vitro consensus sequence, TTGGC(N) 5 CGGAA, including the 5-bp spacer and the preference for an A and T in positions 8 and 12, respectively. Of the 55 binding peaks, 48 (87%) contained at least one NFI-1 motif (see Table 1 ). The majority of peaks contained only one NFI-1 motif (see Table 1 ), although some contained up to 3 motifs as defined by the MDscan generated position weight matrix (Fig. 2C) . We conclude that there is no functional difference between in vivo and in vitro NFI-1 DNA binding specificity.
The Paucity of in Vivo NFI-1 Targets Cannot Be Explained by Overly
Stringent Criteria for Peak Definition. If our threshold for peak definition were too stringent, it would appear that NFI-1 was bound to few genomic targets, when in fact many were bound just under our threshold. If this were the case, the number of peaks detected should increase substantially as our threshold is lowered, and lowering the threshold should continue to capture loci with conserved NFI-1 consensus motifs. However, neither of these predictions holds. Instead, the number of peaks stays fairly constant over a wide range of cutoff values, and use of a lower stringency peak-finding cutoff substantially increases the number of peaks called that lack an NFI-1 motif (Fig. S6) . For example, at the selected 1 ϫ 10 Ϫ12 peak cut-off, 87% of peaks contained an NFI-1 motif, compared to only 44% of peaks at a cut-off of 1 ϫ 10 Ϫ6 .
Sites Bound by NFI-1 in Vivo Exhibit Low Nucleosome Occupancy. We examined the relationship between nucleosome occupancy and NFI-1 binding throughout the genome. For the in vivo targets or the in vitro-selected sequences, computationally predicted (16) and in vivo mapped nucleosome occupancy (17) were plotted surrounding the NFI-1 motifs. At in vivo targets of NFI-1, the low nucleosome occupancy is centered at the NFI-1 motif, whereas high DNA-encoded nucleosome occupancy is predicted (Fig. 3A, Fig. S7 ). This observation is strongest at NFI-1 motifs located within the core promoter (less than 500 bp from the TSS) and is less prevalent at NFI motifs greater than 500 bp from the TSS (Fig. 3B) . Within a 300-bp window surrounding the NFI-1 motif, the median local minimum of nucleosome occupancy occurs at ϩ 6 bp from the motif at in vivo targets. In contrast, at the in vitro selected binding sites, measured nucleosome occupancy is no different from background at the NFI-1 motif, and DNA-encoded nucleosome occupancy is not predicted to be high at NFI-1 motifs (Fig.  3C) . Thus, despite a strongly nucleosome-favoring DNA sequence at sites bound by NFI-1, nucleosomes are depleted from these sites, particularly at core promoters.
NFI-1 Target Genes Tend to Be Highly Conserved in C. briggsae, Mouse,
and Human. Many of the C. elegans NFI-1 target genes are highly conserved across species (Fig. S8A , data not shown), leading us to examine motif conservation at the corresponding promoters in other animals. To find orthologs, for each C. elegans NFI-1 target we obtained the highest Blastp hit in C. briggsae, mouse, and human. We then obtained the 3-kb (C. briggsae) or 5-kb (mouse/human) promoter regions and searched for NFI-1 motifs (see Materials and Methods). Of the 78 C. briggsae orthologs of C. elegans targets, 84% contain promoter NFI-1 motifs, compared to 37% of C. briggsae orthologs of nontargets (P ϭ 9.7 ϫ 10 Ϫ11 ), suggesting that C. elegans NFI-1 targets are functionally conserved in C. briggsae (Fig. S8B) . Using a more stringent motif definition, 90% of C. briggsae orthologs of C. elegans targets have promoter NFI-1 motifs, compared to 24% of C. briggsae orthologs of nontargets (P ϭ 5.3 ϫ 10 Ϫ24 ). Four C. elegans targets [F25H2.5, nhl-2 (Fig. 4A) , pph-4.1, and rpt-6] have NFI motifs in both the orthologous mouse and human promoter (see Fig. S8A ). At Trim2/TRIM2, NFI motifs occur upstream of 3 out of 4 mouse alternative promoters (Fig.  4B ) and both human alternative promoters (Fig. 4C ). This motif occurrence in both the mouse and human ortholog promoters suggests that some C. elegans NFI-1 targets may be conserved in vertebrates (see Fig. S8A ).
Discussion
We examined the in vitro affinity and in vivo binding of a C. elegans transcription factor, NFI-1. We find that NFI-1 binds 55 loci upstream of 85 genes involved predominantly in basal cellular functions, including transcription, translation, biosynthesis, and signaling. While very little functional information is known for over half of NFI-1 targets, a recent article linked NFI-1 target rheb-1 to longevity, raising the possibility that the lifespan phenotype of nfi-1 mutants may be mediated in part through rheb-1 function (18) . The identity of these targets provides insight regarding the types of targets that may be bound by vertebrate NFI orthologs. The majority of the C. elegans NFI-1 targets have well-conserved orthologs in more complex organisms (see Fig. 4 , and Fig. S8 ). Deficiencies in mouse and human NFI proteins show brain and neurological defects, suggesting an important function in neuronal development (2, 3, 19, 20) . Interestingly, 2 of the C. elegans targets (nhl-2 and F25H2.5) whose mouse and human orthologs (Trim2/ Trim32 and Nme2, respectively) have promoter NFI motifs have been linked to neurological defects in mice (20) (21) (22) . In addition, the promoters of C. elegans nhl-2, and both mouse and human homologs of nhl-2 (Trim2/Trim32) contain NFI motifs (see Fig. 4 ). In C. elegans, NHI-2 is involved in miRNA regulation, and Trim32 has been associated with myopathy in humans and defects in neuronal differentiation in mice (20) . In addition, a second nhl-2 ortholog, Trim2, has been associated with neurodegeneration in mice (22) . Most recently, F25H2.5/Nme2 has been shown to have similar regulation in both C. elegans and mouse in response to knockdown of FEH-1/Fe65, a protein involved neuronal development and implicated in the processing of aberrant proteins in Alzheimer's disease (21) . These targets warrant further functional examination in both C. elegans and more complex metazoans, where the function of NFI may be conserved at promoters. A remaining central question is why the NFI consensus sequence is specifically over-represented in the genome, while the number of targets bound in vivo is so small. NFI binding sites are found in of a number of viruses and retroviruses in mammals (23) , raising the possibility that the worm motif TTGGCA(N) 3 TGCCAA could be remnant of a virus or transposon. Indeed, the NFI motif is present in three C. elegans transposon-related repetitive elements [Ce000087, Ce000337, and Ce000357; wormbase release ws193) (24, 25) ]. Detailed examination of the sequence context of these repeat-associated NFI-1 motifs may allow us to determine the biological significance of this unprecedented over-representation of a consensus transcription-factor binding motif.
Despite the specific nature of the motif over-representation, few stringent criteria for peak definition. An alternate technical explanation for the low number of targets in vivo is that because the ChIPs were performed from whole worms, we can detect only targets held in common between all tissues. While many of the NFI-1 target genes are expressed in several tissue types (primarily pharynx, intestine, and body-wall muscle), we identified other targets that appear to show specific expression in single-cell types, such as neurons (26) . While not necessarily an indication of our ChIP, this suggests that we are able to detect tissue-specific NFI-1 targets with our approach. In addition, several loci containing NFI-1 motifs but not bound by NFI-1 in vivo were verified negatives by qPCR (see Fig. S4 ), suggesting a low false negative rate. Therefore, while technical explanations for the low number of targets cannot be ruled out, they seem unlikely.
The low number of in vivo NFI-1 targets, despite the motif over-representation and similarity to the in vitro NFI motif, suggests that additional factors play an important role in site selectivity in vivo. Our demonstration that in vivo-occupied NFI-1 sites tend to be centered within nucleosome-poor regions that are predicted on the basis of DNA sequence to be highly nucleosome occupied, suggests that NFI-1 is directed to targets as a consequence of low nucleosome occupancy introduced by other transacting factors. Alternatively, NFI-1 itself may actively displace nucleosomes. The best-studied chromatin model in which NFI proteins function is the MMTV promoter. Initial studies indicated that the nucleosome phasing was sequencedependent (11) , although more recent work has suggested that both NFI and glucocorticoid receptor (GR) binding may influence the MMTV-promoter chromatin structure (27) . One widely supported model for hormone-induction of MMTV transcription is that NFI binding is normally excluded from the MMTV promoter by the presence of a sequence-dependent phased nucleosome (28) , and that GR-recruited chromatin remodeling allows NFI to bind. Another model has been proposed, in which NFI binds with low affinity to the MMTV promoter and that synergism with GR binding allows for remodeling, high-affinity binding, and transcription activation (27) . Taken together, the evidence suggests that multiple, perhaps synergistic, binding events with an unknown cofactor are likely required to direct NFI-1 to its targets and overcome high DNA-encoded nucleosome occupancy, but a definitive demonstration awaits further study.
Materials and Methods
In Vitro Genomic Selection. In vitro genomic selection was performed as previously described (29) . Sau3AI-digested genomic DNA from a mixed-age population of N2 worms was incubated with NFI-1-GST Sepharose. DNA was eluted with glutathione and purified. DNA was ligated to linkers, PCR amplified, and sub- jected to 2 additional rounds of selection. After the last round of selection and amplification, DNA was TOPO-cloned (Invitrogen) and all clones were sequenced.
DNA-Binding Assays. Gel mobility-shift assays and competition analysis were performed as described previously (6) . Worm extracts were prepared from dounce-homogenized mixed-age worms in buffer described previously (6) . Recombinant GST-NFI-1 protein (100 ng) and the labeled oligonucleotides containing a wild-type NFI binding site (wt) 5ЈAGGTCTGGCTTTGGGCCAAGAGCCGC or a site with a single-point mutation (mut) 5ЈAGGTCTcGCTTTGGGCCAAGAGCCGC shown previously to abolish the binding of vertebrate NFI proteins (30), were used. A 100-fold molar excess of unlabeled PCR amplified DNA from each round of selection was added to the indicated samples.
Chromatin Immunoprecipitation. Rabbit polyclonal antiserum was raised against recombinant NFI-1-GST fusion protein, described above. Antibody recognition of native NFI-1 protein bound to DNA was verified by gel mobility-shift assays (Fig.  S9) . N2 mixed-age worms were cross-linked as previously described (31) . Crosslinked pellets (120 -150 mg) were resuspended in ChIP lysis buffer (Upstate) sonicated using a Branson Sonifier 250 (output 30 and DutyCycle 30% setting) with 15 rounds of 10 1-sec pulses on ice. ChIP was performed using the ChIP assay kit (Upstate) with either 5-l anti-NFI immune serum or preimmune serum with 5% set aside as the input sample. For ChIP-chip, samples were amplified by either ligation-mediated PCR (32) or a modified Whole Genome Amplification protocol [Sigma (33)], as previously described.
Microarrays and Data Extraction. DNA microarrays (Agilent Technologies) covering the entire C. elegans genome with 185,000 probes at an average start-tostart spacing of 600 bp were used for ChIP-chip (GEO Accession GPL7776). Four NFI-1 ChIP biological replicates and 2 NFI-1 preimmune ''mock'' ChIP-chip experiments were performed. Raw intensities for each ChIP were normalized by converting to standard Z-scores, and combined by taking the median of replicates. Raw and processed data can be accessed at NCBI GEO Accession GSE13918. Significant binding peaks were derived using a perl implementation of ChIPOTle (34) . Peak maximum probes were extracted and annotated to the nearest gene using a C. elegans implementation of Cis-element annotation software (35) and hand-checked for accuracy (Wormbase release ws170).
ChIP-chip Data Analysis. A 1,500-bp window centered on the peak maximum probe was repeat masked using RepeatMasker (36) . Peaks were ranked by maximum probe Z-score, and MDscan (15) was used for motif discovery. Matrixscan (32) was used to find motifs using the MDscan-generated positionweight matrix for the top-scoring motif. Distance to nearest TSS mappings, random window generation, and perfect-match motif finding were performed using custom Perl, Ruby, and R scripts (available upon request). Genome browser visualizations were obtained using the UCSC genome browser (http://genome.ucsc.edu), genome release ws170/ce4. Modeling of nucleosome occupancy and MNase mapping of nucleosome occupancy and position (Adjusted Nucleosome Stringency) were derived from published datasets (16, 17) . Raw expression data were obtained from the Stanford Microarray Database (http://smd.stanford.edu/) for a published C. elegans lifecycle time-course (37) . Raw intensities for each expression microarray channel (mixed RNA reference or single stage) were percentile-ranked as an unbiased measure of relative RNA abundance.
Precomputed wormbase blastp hits were used to find orthologs of the C. elegans NFI-1 targets. The lowest e-value hit was chosen and 3 kb (C. briggsae) or 5 kb (mouse/human) upstream of the TSS was analyzed for motifs using Matrixscan (32) using the C. elegans-derived position-weight matrix. C. briggsae sequences and annotations were obtained for wormbase genome release ws190; mouse (Ensembl50/NCBI m37), and human (Ensembl50/NCBI36) sequences and annotations were obtained via Ensembl (http://www.ensembl.org/) and the UCSC genome browser.
qPCR Analysis of ChIP-chip Data. qPCR was used to determine relative amount of specific loci in IP, Input, and Mock (Preimmune) samples. qPCR was performed using iQ SYBR Green Supermix (Bio-Rad) on a Bio-Rad iCycler. One microliter of ChIP DNA or a 1:1,000 Dilution of input DNA was used in duplicate reactions. A locus negative for NFI-1 binding (ama-1) was used as an internal control to normalized quantification in qPCR reactions. Data are expressed as IP/Input where DDCT ϭ (Ct IPlocusX Ϫ CtIPama-1) Ϫ (CtInputlocusX Ϫ Ct Inputama-1).
